Asset Details
Do you wish to reserve the book?
Structure–Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Structure–Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels
Do you wish to request the book?
Structure–Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Structure–Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels
2024
Overview
Gain-of-function mutations in the KCNT1 gene, which encodes the sodium-activated potassium channel known as SLACK, are associated with the rare but devastating developmental and epileptic encephalopathy known as epilepsy of infancy with migrating focal seizures (EIMFS). The design of small molecule inhibitors of SLACK channels represents a potential therapeutic approach to the treatment of EIMFS, other childhood epilepsies, and developmental disorders. Herein, we describe a hit optimization effort centered on a xanthine SLACK inhibitor (8) discovered via a high-throughput screen. Across three distinct regions of the chemotype, we synthesized 58 new analogs and tested each one in a whole-cell automated patch-clamp assay to develop structure–activity relationships for inhibition of SLACK channels. We further evaluated selected analogs for their selectivity versus a variety of other ion channels and for their activity versus clinically relevant SLACK mutants. Selectivity within the series was quite good, including versus hERG. Analog 80 (VU0948578) was a potent inhibitor of WT, A934T, and G288S SLACK, with IC50 values between 0.59 and 0.71 µM across these variants. VU0948578 represents a useful in vitro tool compound from a chemotype that is distinct from previously reported small molecule inhibitors of SLACK channels.
Publisher
MDPI AG,MDPI
Subject
/ CNS
/ EIMFS
/ Epilepsy
/ Humans
/ KCNT1
/ Kinases
/ KNa1.1
/ Mutation
/ Nerve Tissue Proteins - antagonists & inhibitors
/ Nerve Tissue Proteins - genetics
/ Nerve Tissue Proteins - metabolism
/ Potassium Channel Blockers - chemistry
/ Potassium Channel Blockers - pharmacology
/ Potassium Channels, Sodium-Activated
/ Proteins
/ SLACK
/ Slo2.2
/ Structure-Activity Relationship
/ Xanthine
We currently cannot retrieve any items related to this title. Kindly check back at a later time.